Figure 1.

Mandatory immunisation coverage for 10 vaccine-preventable diseases according to disease and vaccination doses, Serbia, 2000–2017

BCG: Bacillus Calmette–Guérin vaccine; bOPV: bivalent oral poliovaccine; DT: diphtheria and tetanus toxoids booster for children; dT: diphtheria and tetanus toxoids booster for adults; DTaP-IPV-Hib: diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus and conjugated vaccine against diseases caused by Haemophilus influenzae type b; DTP: diphtheria and tetanus toxoids whole-cell pertussis vaccine; Hep B: monovalent vaccine against hepatitis B; MMR: measles, mumps and rubella; tOPV: trivalent oral poliovaccine, R1: first revaccination; R2: second revaccination; R3: third revaccination.

A. Primary vaccination against tuberculosis (BCG), hepatitis B with three doses of HepB (HepB3) among infants and at age 12 years and against diseases caused by Hib with three doses of Hib vaccine (Hib3). The monitoring of BCG vaccination coverage from 2000 to 2003 was organised by the National Institute of Lung Diseases so data on BCG vaccination coverage in the National Institute of Public Health of Serbia are available from 2004. HepB3 vaccination for infants was introduced in 2005. HepB3 at 12 years of age as well as Hib vaccination were introduced in 2006.

B. Primary vaccination against poliomyelitis (three vaccine doses) with tOPV3/DTaP-IPV-Hib3, as well as first (tOPV/DTaP-IPV-Hib R1), second (tOPV/bOPV R2) and third (tOPV/bOPV R3) revaccination.

C. Primary vaccination against diphtheria, tetanus and pertussis (three doses) with DTP3/DTaP-IPV-Hib3 and first revaccination (DTP/DTaP-IPV-Hib R1), as well as second (DT R2) and third (dT R3) revaccination for diphtheria and tetanus.

D. Vaccination against MMR. The second dose of MMR vaccine has been administered at 12 years of age since the introduction of the vaccine in 1994. In 2006 the second dose of MMR was also provided before enrolment in elementary school. During the period 2006–2011 the second dose of MMR was administered both in children aged 12 years (born between 1994 and 1999) and before enrolment in elementary school (children born between 2000 and 2005). After 2011, the second dose of MMR was administered only before enrolment in elementary school.